Accessibility Menu
Evolent Health Stock Quote

Evolent Health (NYSE: EVH)

$8.08
(-1.2%)
-0.10
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$8.08
Daily Change
(-1.2%) $0.10
Day's Range
$8.01 - $8.3
Previous Close
$8.08
Open
$8.2
Beta
0.99
Volume
1,738,467
Average Volume
2,960,829
Market Cap
961.2M
Market Cap / Employee
$8.18M
52wk Range
$7.06 - $25.22
Revenue
-
Gross Margin
0.12%
Dividend Yield
N/A
EPS
-$1.61
CAPs Rating
-
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Evolent Health Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
EVH-64.73%-23.55%-5.23%-57%
S&P+15.06%+95.03%+14.29%+222%

Evolent Health Company Info

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$444.33M-31.3%
Gross Profit$76.94M0.4%
Gross Margin17.32%5.5%
Market Cap$1.32B-40.5%
Market Cap / Employee$0.29M0.0%
Employees4.5K-4.3%
Net Income-$19.90M-1346.7%
EBITDA$27.25M-32.6%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$175.36M44.6%
Accounts Receivable$358.76M-4.0%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$885.67M8.8%
Short Term Debt$196.33M3101.2%

Ratios

Q2 2025YOY Change
Return On Assets-5.29%-2.4%
Return On Invested Capital-9.77%4.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$39.10M-373.2%
Operating Free Cash Flow-$30.33M-241.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book3.081.251.091.39-33.34%
Price to Sales1.320.510.460.59-36.22%
Price to Tangible Book Value-4.19-1.63-1.33-1.50-45.26%
Price to Free Cash Flow TTM39.4733.9616.8036.44-
Enterprise Value to EBITDA227.0368.0370.1081.1513.50%
Free Cash Flow Yield2.5%2.9%6.0%2.7%-
Return on Equity-6.8%-6.0%-11.0%-13.4%93.03%
Total Debt$822.37M$903.85M$1.06B$1.08B31.96%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.